Insider Transactions in Q2 2021 at Pandion Therapeutics, Inc. (PAND)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 01
2021
|
Eric D Larson Vice President, Finance |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
22,125
-100.0%
|
$1,327,500
$60.0 P/Share
|
|
Apr 01
2021
|
Jill Carroll Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
5,674,221
-100.0%
|
$340,453,260
$60.0 P/Share
|
|
Apr 01
2021
|
Donald Frail Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
61,113
-100.0%
|
$3,666,780
$60.0 P/Share
|
|
Apr 01
2021
|
Nancy Stagliano Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
73,067
-100.0%
|
$4,384,020
$60.0 P/Share
|
|
Apr 01
2021
|
Nancy Stagliano Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
1,000
-100.0%
|
$60,000
$60.0 P/Share
|
|
Apr 01
2021
|
John Sundy Chief Medical Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
115,826
-100.0%
|
$6,949,560
$60.0 P/Share
|
|
Apr 01
2021
|
Daniel J. Becker Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
2,827,883
-100.0%
|
$169,672,980
$60.0 P/Share
|
|
Apr 01
2021
|
Daniel J. Becker Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
1,000
-100.0%
|
$60,000
$60.0 P/Share
|
|
Apr 01
2021
|
Christopher Fuglesang Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
2,131,135
-100.0%
|
$127,868,100
$60.0 P/Share
|
|
Apr 01
2021
|
Rahul Kakkar Chief Executive Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
702,515
-100.0%
|
$42,150,900
$60.0 P/Share
|
|
Apr 01
2021
|
Rahul Kakkar Chief Executive Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
14,000
-100.0%
|
$840,000
$60.0 P/Share
|
|
Apr 01
2021
|
Gregg Beloff Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
13,196
-100.0%
|
$791,760
$60.0 P/Share
|
|
Apr 01
2021
|
Edward D. Freedman Chief Operating Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
54,460
-100.0%
|
$3,267,600
$60.0 P/Share
|
|
Apr 01
2021
|
Alan L Crane Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
3,537,736
-100.0%
|
$212,264,160
$60.0 P/Share
|
|
Apr 01
2021
|
Alan L Crane Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
84,158
-100.0%
|
$5,049,480
$60.0 P/Share
|
|
Apr 01
2021
|
Vikas Goyal Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
87,764
-100.0%
|
$5,265,840
$60.0 P/Share
|
|
Apr 01
2021
|
Joanne L. Viney Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
1,200
-100.0%
|
$72,000
$60.0 P/Share
|
|
Apr 01
2021
|
Joanne L. Viney Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
503,254
-100.0%
|
$30,195,240
$60.0 P/Share
|